Category: Adjunctive to Chemo & Radiation

Neutropenic patients can receive blood cell boosters (growth factors) such as Neulasta or Neupogen® (filgrastim), which are given by injection during chemotherapy cycles. Neulasta and Neupogen have demonstrated the ability to reduce infections, hospitalizations, medical cost, dose delays, and death associated with infection in neutropenic patients. The FDA has approved Neulasta (a longer-acting form of Neupogen) to be given 14 days before initiation of chemotherapy or at least 24 hours following initiation of chemotherapy (however, this requires patients to return to the medical office or hospital one day following chemotherapy for administration).

Google it: Neulasta